nervous system development are likely to be more complex, as central neurons commonly respond to several and Donald C. Lo † * Howard Hughes Medical Institute neurotrophic factors, and their survival and differentiation in vitro requires multiple neurotrophic factors † Department of Neurobiology Duke University Medical Center (Snider, 1994; Meyer-Franke et al., 1995) . In cerebral cortex, neurons in each layer express several neuroDurham, North Carolina, 27710 trophins and Trk receptors (Merlio et al., 1992; Kokaia et al., 1993; Miranda et al., 1993; Ringstedt et al., 1993; Snider, 1994; Lindsay et al., 1994) . One explanation for Summary this is that multiple neurotrophins provide redundant growth and differentiation signals, but a more interesting Neurons within each layer of cerebral cortex express multiple members of the neurotrophin family and their possibility is that the developing cortex uses multiple neurotrophic signals to direct distinct aspects of neucorresponding receptors. This multiplicity could provide functional redundancy; alternatively, different ronal growth and differentiation. We have addressed this issue by studying how enneurotrophins may direct distinct aspects of cortical neuronal growth and differentiation. By neutralizing dogenous neurotrophins regulate the dendritic growth of pyramidal neurons. During development, pyramidal endogenous neurotrophins in organotypic slices of developing cortex with Trk receptor bodies (Trk-IgGs), neurons undergo highly-regulated patterns of dendritic growth that result in the stereotypic neuronal morpholowe found that BDNF and NT-3 oppose one another in regulating the dendritic growth of pyramidal neurons.
Introduction tion. Thus, in cortex, multiple neurotrophins are used instructively to direct different aspects of dendritic Although the neurotrophins are a family of four structurally related proteins with similar functions in promoting growth as individual neurons and neural circuits develop. neuronal survival and/or differentiation in the peripheral nervous system, their roles in the central nervous system remain controversial. In the periphery, the survival and Results differentiation of particular neurons generally depends on individual neurotrophins (reviewed by Snider, 1994;  Neurotrophin signaling in organotypic brain slices of P14 ferret visual cortex was manipulated in two ways: by Lindsay et al., 1994) . The roles of neurotrophins in central Changes in dendritic complexity of pyramidal neurons from layers 4 and 6 are summarized for visual cortical slices treated for 36 hr with 200 ng/ml BDNF and NT-3 (see also McAllister et al., 1995) . Dendritic complexity is described in terms of a dendrite modification index (DMI; see Experimental Procedures): a zero value on these graphs indicates no statistically significant difference from untreated neurons, an increase in DMI reflects an increase in dendritic complexity, and a decrease in DMI reflects a decrease in dendritic complexity. (A) Exogenous BDNF stimulates dendritic growth by almost doubling the complexity of basal dendrites of layer 4 neurons, while exogenous NT-3 has essentially no effect. (B) In contrast, growth of layer 6 basal dendrites is stimulated by NT-3 but inhibited by BDNF. (A) Endogenous neurotrophins are required for normal dendritic development in cortical pyramidal neurons. Representative camera lucida reconstructions of neurons from untreated slices and slices treated with each of the Trk receptor bodies (20 g/ml) are shown. Neutralizing endogenous BDNF and NT-4/5 with TrkB-IgG (upper right) caused pronounced decreases in the growth of basal dendrites, while neutralizing NGF with TrkA-IgG (lower left) had no significant effect compared to untreated neurons (upper left) . Surprisingly, neutralizing NT-3 with TrkC-IgG dramatically enhanced dendritic arbors (lower right). Blocking endogenous neurotrophins had no substantial effect on apical dendritic growth. Scale bar, 30 m. (B) Opposite effects of endogenous BDNF and NT-3 on dendritic growth. Changes in dendritic complexity caused by treatment with each of the receptor bodies (20 g/ml) for basal (A) and apical (B) dendrites of pyramidal neurons in layer 4. Left graph: neutralizing endogenous BDNF with TrkB-IgG decreased dendritic complexity by over 50% compared with untreated neurons, while neutralizing endogenous NGF with TrkA-IgG had no effect on dendritic growth. Neutralizing endogenous NT-3 with TrkC-IgG markedly increased dendritic complexity, by almost twofold. Right graph: neutralizing endogenous neurotrophins had little effect on growth of apical dendrites. addition of exogenous neurotrophins to augment neurolayer 4 neurons, and 3) endogenous NT-3 limits dendritic growth or induces dendritic retraction. trophin levels or by addition of Trk receptor bodies (Trk-IgGs) to neutralize endogenous neurotrophins.
The effects of TrkB-IgG and TrkC-IgG were dosedependent; TrkB-IgG first inhibited dendritic growth at Trk-IgGs are chimeric recombinant proteins consisting of the ligand-binding domains of each of the Trk recep-20 g/ml while TrkC-IgG elicited growth even at 1 g/ml.
All three receptor bodies were recoverable from treated tors fused to the Fc domain of human IgG (Shelton et al., 1995) . These fusion proteins combine the stability slices at similar efficiencies ( Figure 4A ), indicating that the stability of Trk-IgGs and their penetration into slices and solubility of immunoglobulins with the high affinity and specificity of native TrkA, TrkB, and TrkC recepwere similar in all cases, and that the absence of effect of TrkA-IgG was not due to its degradation. The specifictors, and are superior to function-blocking antibodies in their ability to neutralize specific neurotrophins in ity of the Trk-IgGs was confirmed by competition with BDNF: the growth-promoting effects of exogenous intact neural tissue.
BDNF were blocked by TrkB-IgG but not by TrkA-IgG or TrkC-IgG ( Figure 4B ).
Endogenous Neurotrophins Regulate Dendritic Growth of Layer 4 Cortical Pyramidal Neurons
As expected from the extensive dendritic enhancement Opposing Actions of Endogenous BDNF and NT-3 on Dendritic Growth of Layer 4 Neurons elicited by exogenous TrkB ligands (Figure 1 ; see also McAllister et al., 1995) , neutralizing endogenous BDNF Neutralizing endogenous NT-3 caused dendritic growth in layer 4 that was strikingly similar to that induced by and NT-4/5 with TrkB-IgG markedly reduced dendritic complexity ( Figure 2 ; Table 1 ) by causing retraction of exogenous BDNF ( Figure 5 ). Neurons showed similar increases in total dendritic length and in the number of existing basal dendrites ( Figure 3) ; apical dendrites were only modestly affected (Figure 2 ). In contrast, neutralizprimary dendrites, higher-order dendritic branches, and protospines (Table 2 ). Based on these similarities, we ing endogenous NGF with TrkA-IgG had no effect on basal dendrites (Figure 2) , consistent with the minor hypothesized that the growth produced by blocking endogenous NT-3 resulted from the actions of endogenous effects of exogenous NGF on dendritic growth (McAllister et al., 1995) .
BDNF. If this were true, then dendritic growth caused by TrkC-IgG should be prevented by neutralizing endogAs exogenous NT-3 caused no changes in dendritic growth of layer 4 neurons (Figure 1 ; see also McAllister enous BDNF with TrkB-IgG. In fact, treatment with both TrkC-IgG and TrkB-IgG et al., 1995), we predicted that neutralizing endogenous NT-3 would also have little effect. Surprisingly, treatment completely abolished the dendritic growth caused by TrkC-IgG treatment alone ( Figure 6A ), indicating that with TrkC-IgG elicited dramatic growth of basal dendrites (Figure 2) . Together, these effects of the Trk-IgGs the dendritic growth caused by TrkC-IgG treatment was mediated by endogenous BDNF. Layer 4 neurons indicated that 1) endogenous neurotrophins are biologically active in developing visual cortex, 2) endogenous treated with both receptor bodies had dendrites whose complexity was intermediate between control and TrkBTrkB ligands are necessary for basal dendritic growth of IgG-treated values. Dendritic growth of neurons treated with both receptor bodies was decreased by 37% compared to the 54% decrease resulting from treatment with TrkB-IgG alone (these values were significantly different at the P Ͻ 0.05 level; Figure 6B ).
These findings implied that exogenous BDNF and NT-3 should also have opposing effects on dendritic growth. Treatment of slices with both factors indicated that this was true: the potent growth-promoting effects of exogenous BDNF were abolished by equimolar levels of exogenous NT-3 (Figure 7 ). Even at 10-fold lower concentrations, NT-3 completely inhibited the effects of exogenous BDNF in every parameter of dendritic growth ( Figure 8A ; Table 3 ). These effects were specific to NT-3, as cotreatment with NGF had no effect on the dendritic growth caused by exogenous BDNF ( Figure 8B ). TrkB-IgG increased dendritic growth ( Figure 9 ). The dendritic growth induced by exogenous NT-3 was re-BDNF and NT-3 induced CREB phosphorylation in markably similar to that caused by TrkB-IgG ( Figure 9 ; ‫%05ف‬ of dissociated layer 4 cells (the maximum per- Table 4 ), suggesting that the growth caused by neutralizcentage of cells capable of CREB phosphorylation as ing endogenous BDNF was mediated by endogenous assessed by forskolin ϩ high potassium stimulation), NT-3. If so, then the dendritic growth caused by TrkBwhile only 3% of untreated cells were phospho-CREB IgG should be prevented by neutralizing endogenous positive ( Figure 11 ; Table 5 ). Consistent with observed NT-3 with TrkC-IgG.
effects of NGF on dendritic growth ( Figure 8B ; see also As predicted, treatment with both TrkC-IgG and TrkBMcAllister et al., 1995) , NGF also induced CREB phosIgG completely prevented the dendritic growth caused phorylation in ‫%05ف‬ of treated cells (Table 5) . Untreated by TrkB-IgG alone (Figures 9 and 10A), indicating that cells were at most only lightly stained for phosphothe dendritic growth elicited by TrkB-IgG was mediated CREB, while most of the stained, treated cells were by endogenous NT-3. Layer 6 neurons treated with both clearly darkly stained ( Figure 11 ; Table 5 ). Most imporreceptor bodies were almost indistinguishable from tantly, treatment of cells with BDNF and NT-3 together control neurons, suggesting that endogenous BDNF did not increase the percentage of phospho-CREB posicauses retraction of basal dendrites, while endogenous tive cells over that observed after treatment with either NT-3 induces dendritic growth. Exogenous BDNF and factor alone ( Figure 11 ; Table 5 ), indicating that BDNF NT-3 also had opposing effects on dendritic growth of and NT-3 act directly on mostly overlapping, if not identilayer 6 neurons: even a 10-fold lower concentration of cal, neuronal populations in layer 4. exogenous BDNF completely blocked the dendritic growth induced by exogenous NT-3 (Figures 9 and 10B; Discussion Table 4 ).
These results demonstrate that endogenous neurotro-BDNF and NT-3 Act Directly on Layer 4 Neurons phins are biologically active in developing visual cortex To examine whether BDNF and NT-3 could act directly and that they can either stimulate or inhibit dendritic on layer 4 pyramidal neurons, or whether they must growth. Moreover, endogenous BDNF and NT-3 can act affect dendritic growth in layer 4 via other cell types directly upon the same neuronal populations and have present in cortex, acutely-dissociated layer 4 neurons opposing effects on dendritic growth. In layer 4, BDNF were assessed for phosphorylation of cAMP-response stimulates dendritic growth, while NT-3 inhibits dendritic element binding protein (CREB) in response to neurogrowth. These roles for BDNF and NT-3 are reversed in trophins Ghosh et al., 1994) . CREB the regulation of dendritic growth in layer 6. phosphorylation occurs downstream of activation of all three Trk receptors and serves as an index of neuroEndogenous Neurotrophins Regulate Dendritic trophin responsiveness. CREB phosphorylation was deGrowth of Cortical Pyramidal Neurons tected using an antibody specific for CREB phosphoryAs suggested by the strong effects of exogenous neurotrophins on the dendritic growth of cortical pyramidal lation at serine-133 . (A) Trk receptor bodies penetrate cultured slices and remain intact. Trk-IgGs were recovered from cultured slices treated for 36 hr with 20 g/ml of each receptor body by homogenization and extraction of Trk-IgGs with Protein-G agarose, as described in the Experimental Procedures. Recovered proteins were separated by SDS-PAGE and immunoblotted with an anti-human IgG antibody to visualize Trk-IgGs. The upper band with apparent molecular weight of 92 kDa corresponds to the Trk-IgGs and is not present in homogenates of untreated (UT) slices; the lower band at ‫05ف‬ kDa is non-specific and is present in all slices regardless of treatment. The similarity of recovery of TrkA-IgG, TrkB-IgG, and TrkC-IgG indicated that these receptor bodies penetrated slices to equivalent degrees and remained intact during the treatment period. No proteolytic fragments containing the human IgG Fc domain of the receptor body were observed. (B) TrkB-IgG, but not TrkA-IgG or TrkC-IgG, inhibits the effects of exogenous BDNF. The specificity of each of the receptor bodies was assayed by their ability to inhibit the growthpromoting effects of exogenous BDNF on layer 4 neurons. TrkB-IgG showed dosedependent inhibition of the effects of 200 ng/ ml of BDNF, with complete inhibition occurring at an equimolar equivalent of TrkBIgG (2 g/ml, shown in bold, left); a 10-fold lower concentration of TrkB-IgG had no inhibitory effect. In contrast, even at 10-fold molar excess (22 g/ml), neither TrkA-IgG nor TrkC-IgG inhibited the dendritic growth stimulated by exogenous BDNF (right). neurons ( Figure 1 ; see also McAllister et al., 1995) , we that calculated for BDNF in adult pig brain (Hofer and Barde, 1988) , which may reflect local actions of endogefound that endogenous neurotrophins are required for normal dendritic development. Consistent with the nous BDNF that require higher concentrations of TrkBIgG for neutralization. In any case, these estimates are layer-specific effects of exogenous neurotrophins, dendritic growth of layer 4 neurons requires endogenous upper bounds because of immeasurable factors such as internalization or degradation of receptor bodies, which BDNF, while growth of layer 6 cells requires endogenous NT-3. Despite their involvement in basal dendritic would cause us to overestimate the active concentrations of Trk-IgGs in treated slices. growth and the effects of exogenous neurotrophin application, endogenous neurotrophins do not appear to regulate apical dendritic growth. This difference of growth Endogenous Neurotrophins Inhibit As Well As Stimulate Dendritic Growth regulation in apical versus basal dendritic compartments is consistent with our previous observations usAlthough neurotrophins are generally considered to be growth-promoting factors, we found, surprisingly, that ing exogenous neurotrophins (McAllister et al., 1995) .
Recovery of intact Trk receptor bodies from treated endogenous NT-3 in layer 4 and BDNF in layer 6 both strongly inhibited basal dendritic growth. Moreover, slices ( Figure 4A ) allowed us to estimate an upper bound for the effective physiological concentrations of endogesince neutralizing both BDNF and NT-3 resulted in dendritic complexities intermediate to those values caused nous neurotrophins. Penetration of slices was similar for all receptor bodies; at the concentrations used in by neutralizing either factor alone, the growth-inhibitory effects of neurotrophins are likely to involve active re- Figure 4A (20 g/ml), each slice was estimated to contain ‫5.2ف‬ ng of Trk-IgGs at the end of the treatment traction of dendrites. For example, Figure 10A illustrates two conditions in which endogenous NT-3 was neutralperiod. Since Trk-IgGs neutralize neurotrophins at equimolar ratios, we calculated the active concentration of ized: treatment with TrkC-IgG alone and treatment with TrkB-IgG and TrkC-IgG together. The only difference neurotrophins corresponding to the threshold doses of Trk-IgGs required for affecting dendritic growth (20 g/ between these two conditions is that endogenous BDNF is still active in the presence of TrkC-IgG alone. Since ml for TrkB-IgG and 1 g/ml for TrkC-IgG). Assuming an extracellular volume of 10%, we estimate that 250 the dendrite modification index (DMI) is decreased in this condition, the simplest interpretation is that endogeng/ml BDNF and 13 ng/ml NT-3 are active in developing cortical tissue. The estimate for BDNF is higher than nous BDNF caused retraction of existing dendrites. 
BDNF and NT-3 Have Opposing Roles
One explanation for these results is that NT-3 and BDNF directly interact by competing for binding to TrkB. in Regulating Dendritic Growth Most importantly, we found that endogenous BDNF and TrkB can act as a receptor for NT-3 (Maisonpierre, 1990; Glass et al., 1991; Klein et al., 1991; Soppet et al., 1991 ; NT-3 have opposing effects on dendritic growth in layer 4 and layer 6 pyramidal neurons, suggesting that BDNF Squinto et al., 1991; Rodriguez-Tebar et al., 1992 ) and can inhibit BDNF-mediated neuronal survival (Dechant and NT-3 are part of a "push-pull" signaling system that regulates dendritic development of individual neurons et al., 1993). In most cases, NT-3 binds to TrkB with lower affinity than BDNF (Maisonpierre et al., 1990 ; Klein in response to multiple environmental cues. Although the loci of action of endogenous BDNF and NT-3 remain et al., 1991; Altar et al., 1994; but see also Ip et al., 1993) , and physiological concentrations of NT-3 do not to be determined, two observations make it likely that these neurotrophins both act directly on layer 4 and appreciably activate TrkB in neuronal cell contexts . Most relevant to our study, NT-3 does not layer 6 neurons: 1) in acutely-dissociated layer 4 neurons, BDNF and NT-3 together induced CREB phosphorsignificantly cross-link to TrkB in P10 ferret visual cortex (Allendoerfer et al., 1994) . The possibility of receptorylation to the same extent as either factor alone, indicating that largely overlapping or identical populations of based competition is further diminished by our finding that even at a concentration 10-fold lower than that of neurons respond to both factors ( Figure 11) ; and 2) the actions of BDNF and NT-3 are reversed in layer 6 com-BDNF, NT-3 completely inhibits BDNF-induced growth of layer 4 neurons (Figure 8 ). These observations sugpared with layer 4, i.e., BDNF is stimulatory and NT-3 inhibitory in layer 4, while NT-3 is stimulatory and BDNF gest that the opposing actions of BDNF and NT-3 in developing cortex are not likely to occur through compeinhibitory in layer 6 (Figures 6, 9, and 10) . tition at the receptor, but rather through interactions at subsequent stages of signal transduction (reviewed by Kalcheim et al., 1992; Kalcheim, 1996) . By analogy, since neurons in different cortical layers are phenotypigrowth of pyramidal neurons in developing ferret visual cortex. Moreover, neurotrophins clearly function in both cally distinct, it is plausible that differences in their signal transduction systems and patterns of gene expression positive and negative directions to regulate dendritic growth. Such a push-pull system for regulating dendritic could lead to quite different dendritic growth responses to the same neurotrophin signals.
growth is reminiscent of the interactions between, and 1995, 1996) . Culture medium (1 ml; 50% BME, 25% HBSS, 25% neurons from untreated slices and slices treated with either BDNF horse serum [Hyclone] , 330 mM dextrose, 10 mM HEPES, and (200 ng/ml), NT-3 (200 ng/ml), or both neurotrophins together. BDNF 10 U/ml penicillin-streptomycin; GIBCO) was placed under each treatment caused striking growth of basal dendrites while NT-3 had insert, and the plates were incubated in 5% CO 2 at 37ЊC for 36 hr. minimal effects on dendritic growth (see also McAllister et al., 1995) .
Ferrets were obtained from Marshall Farms (North Rose, NY). However, when slices were treated with both factors together, exogenous NT-3 blocked the growth-promoting effects of exogenous Particle-Mediated Gene Transfer BDNF. Dendritic arbors of neurons treated with both factors were Particle-mediated gene transfer was used to visualize large numbers similar to those of untreated cells and distinct from those of BDNFof neurons in the slices; details of the procedure have been pretreated cells. Scale bar, 20 m.
viously described (Lo et al., 1994; McAllister et al., 1995) . Particlemediated gene transfer of EF␤gal (lacZ driven by the Xenopus EF1␣ the importance of cell context for, stimulators and inhibipromoter [Krieg et al., 1989] ) was performed within 1-4 hr after tors of axon guidance (reviewed by Tessier-Lavigne and slice preparation, using a Bio-Rad PDS-1000/He biolistics device. Following transfection, slices were returned to the incubator and Goodman, 1996) . Although the neurotrophins have gen- and function throughout the brain.
Experimental Procedures Immunocytochemistry
Transfected neurons were visualized by immunocytochemistry using an affinity-purified rabbit antibody to ␤-galactosidase (1:500; Preparation of Visual Cortex Slice Cultures Coronal slices (400 m) of P14 ferret visual cortex were prepared 5Ј-3Ј) and a Cy3-conjugated goat anti-rabbit secondary antibody (1:100; Chemicon), as previously described (McAllister et al., 1995) . and cultured as previously described (Katz, 1987 ; McAllister et al., The 92% increase in basal dendrites elicited by BDNF is completely blocked by 20 ng/ml NT3 (last column) but not significantly affected by 200 ng/ml NGF (fourth column). Conventions as in Table 1 .
Slices were counterstained with 100 M DAPI (4Ј,6-diamidino-2-dendrite (m) and the numbers of primary dendrites, branches of each dendrite, and protospines (spine-like processes less than 0.5 phenylindole) to determine the layer-specific location of each neuron.
m), as previously described (McAllister et al., 1995) .
Cell Selection, Reconstruction, and Analysis Calculation of the DMI For each experimental condition, ‫04ف‬ cells from two ferrets, each
The DMI summarizes the average of the four parameters for each from a separate litter, were used. Control cells (40-60) were always treatment into a value that conveys the direction and magnitude of obtained from animals in each litter to facilitate comparison with resulting dendritic changes. The DMI is simply a weighted sum of experimentally treated cells. The first 40 pyramidal neurons that the ratios for each of the four measures of dendritic growth in treated were stained sufficiently to distinguish the smallest processes were versus untreated cells, calculated as: reconstructed with a camera lucida using a 63ϫ objective and a DMI ϭ ͚ i C i · T i /UT i standard rhodamine epifluorescence filter set on a Zeiss Axiophot microscope. From these drawings, four parameters of dendritic growth were directly measured or counted: the total length of each where T i is the value of a given parameter i after treatment, UTi is the In layer 6, the roles of BDNF and NT3 are reversed. The ratio of the average value for treated cells to the average untreated value for each parameter of dendritic growth. Conventions as in Table 1. value in untreated slices, and Ci is a normalized weighting constant any individual parameter of dendritic growth, each T/UT value is set to 1, resulting in a DMI for that experimental condition equal to 1. whose magnitude depends on the parameter (see McAllister et al., 1995 for additional details). The ratio T/UT is set to a value of 1 for Similarly, for an experimental condition that doubles the values for each parameter of dendritic growth in a statistically significant mancases in which treated values (T) are not significantly different from control values (UT) at the P Ͻ 0.05 confidence level by ANOVA. For ner, the resulting DMI will be equal to 2. Statistical significance is thus intrinsic to the DMI calculation, and error bars are not shown an experimental condition with no statistically significant effect on in graphs of DMI values.
Recovery of Receptor Bodies from Treated Slices
Slices were cultured and treated with 20 g/ml of each of the receptor bodies as described. After 36 hr in vitro, slices were homogenized in 100 l cell lysis buffer ; 0.14 U/ml aprotonin, 1 mM PMSF, 1 mM Na orthovanadate, 1% NP-40, 0.5% deoxycholate, and 0.1% SDS in calcium-and magnesium-free PBS). Cell debris was removed by brief centrifugation; supernatant was removed and incubated with 1/2 volume washed Protein G agarose (GIBCO) at 4ЊC for 1 hr, with rocking. Beads were then collected by centrifugation and run on 7.5% polyacrylamide gels with receptor body and molecular weight standards in parallel lanes. Gels were transferred onto PVDF paper (Bio-Rad) and blocked with PBS containing 0.05% Tween and 5% BSA. Trk receptor bodies were then visualized by immunoblotting with a goat anti-human IgG antibody (1:500; Boehringer-Mannheim) followed by an alkaline phosphatase-conjugated anti-goat IgG antibody (1:500, Boehringer Mannheim). Chemiluminescence was generated using the CDP-Star substrate (New England BioLabs) and detected with Hyperfilm-ECL (Amersham). 
Dissociation of Cortical Neurons

